Healthcare

GHO Capital raises over $1bn, Eyes Biotech Outsourcing Services

4 days ago   |   By Xconomy

GHO Capital will use the money raised to invest in healthcare, including outsourced service providers, which are seeing demand from smaller biotechs, according to a Jefferies analyst. GHO Capital raised €975 million , which exceeded its €800 million target, and is 50% larger than its 2015 maiden fund. Fund II LP is the largest specialist private equity fund dedicated to European healthcare, according to Preqin data. GHO plays in the mid-market space, targeting deals with an initial enterprise value of around €100-500 million. Though for particularly attractive prospects, the company says...
Read more ...

 


Search by Tags

   Healthcare      Biotech      BioTech      National      National blog main      Financing      GHO Capital      Healthcare      Life Sciences  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

IAmScience Mannie Liscum

IAmScience Mannie Liscum

For Mannie Liscum, thinking is a privilege, and his job gives him the chance to be fascinated by human's capacity to conceptualize and learn new things. “It's my goal to use as... Read more ...

MiR-552 promotes ovarian cancer progression by regulating PTEN pathway

Abstract Background Increasing researches have demonstrated the critical functions of MicroRNAs in the progression of malignant tumors, including ovarian cancer. It was... Read more ...

Exploration of cryptic organic photosensitive compound as Zincphyrin IV in...

Abstract Zincphyrin IV is a potential organic photosensitizer which is of significant interest for applications in biomedicine, materials science, agriculture , and chemistry... Read more ...

Three transcriptional regulators positively regulate the biosynthesis of...

Abstract Polycyclic tetramate macrolactams are a widely distributed class of structurally complex natural products, and most of them exhibit multiple biological activities... Read more ...

Faint gray bands in Drosophila melanogaster polytene chromosomes are formed...

Abstract In Drosophila melanogaster , the chromatin of interphase polytene chromosomes appears as alternating decondensed interbands and dense black or thin gray bands... Read more ...

A New Risk-Based Fuzzy Cognitive Model and Its Application to Decision-Making

Abstract Cognitive information in real-world decision-making problems is usually associated with all sorts of ambiguities and uncertainties. Fuzzy sets have been proposed as a... Read more ...

Analyzing the action of evolutionarily conserved modules on HMW-GS 1Ax1...

Abstract Key message The specific and high-level expression of 1Ax1 is determined by different promoter regions. HMW-GS synthesis occurs in aleurone layer cells. Heterologous... Read more ...

Achromobacter sp. FB-14 harboring ACC deaminase activity augmented rice...

Abstract Soil salinity is one of the major plant growth and yield-limiting constraints in arid and semi-arid regions of the world. In addition to the oxidative damage... Read more ...

Construction and Characterization of UBC4 Mutants with Single Residues...

Abstract Ubiquitination is tightly regulated to control degradation, localization and function of various proteins. Ubiquitination is catalysed by three enzymes, namely E1, E2... Read more ...

SPG8 mutations in Italian families: clinical data and literature review

Abstract Background Spastic paraplegia type 8 is an autosomal-dominant form of hereditary spastic paraplegia caused by a mutation in the KIAA0196 gene. SPG8 accounts for 1% of... Read more ...